Targeting PVR (CD155) and Its Receptors in Anti-Tumor Therapy

Cellular and Molecular Immunology - United States
doi 10.1038/s41423-018-0168-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Phosphodiesterases in Anti-Platelet Therapy

Handbook of Experimental Pharmacology
BiochemistryToxicologyPharmaceuticsPharmacology
2012English

Targeting Tumor-Intrinsic Hexosamine Biosynthesis Sensitizes Pancreatic Cancer to Anti-Pd1 Therapy

Journal of Clinical Investigation
Medicine
2019English

Targeting IL-2 Receptors for Diagnosis and Therapy

Japanese Journal of Clinical Immunology
1994English

Table 2: Anti-Tumor Agents for Targeting Hypoxia-Induced CA IX for Therapy and Diagnosis.

English

Targeting Peripheral Opioid Receptors to Promote Analgesic and Anti-Inflammatory Actions

Frontiers in Pharmacology
Pharmacology
2013English

Proteome-Based Anti-Tumor Cell Therapy

2014English

Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives With Bombesin, Neurotensin, and Neuropeptide-Y Receptors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

663. Targeting Tumor-Associated Macrophages for Cancer Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Tim-3 and Its Role in Regulating Anti-Tumor Immunity

Immunological Reviews
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy